Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0022702,
umls-concept:C0026336,
umls-concept:C0034802,
umls-concept:C0183683,
umls-concept:C0242485,
umls-concept:C0344211,
umls-concept:C0376525,
umls-concept:C0596448,
umls-concept:C0596973,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1514758,
umls-concept:C1521721,
umls-concept:C1522951,
umls-concept:C1749467
|
pubmed:issue |
32
|
pubmed:dateCreated |
1993-9-16
|
pubmed:abstractText |
We have tested one aspect of the allosteric dimerization model for the activation of EGF receptor (EGFR) by EGF: whether EGF binding favors dimerization of the receptor. For this to be true, EGF molecules must bind with higher affinity to dimeric receptors than to monomeric receptors. We have tested this directly in a defined system using the soluble, extracellular ligand binding domain of EGFR monomers (sEGFR) and sEGFR dimers stabilized by treatment with a covalent cross-linking agent. We describe real-time kinetic measurements of EGF binding to receptor monomers and dimers employing the method of total internal reflection (surface plasmon resonance). Our data show that sEGFR dimers bound EGF with 30-40-fold higher affinity [KD = (2-3) x 10(-8) M] than did sEGFR monomers. The enhanced binding affinity of sEGFR dimers resulted mainly from a reduced off-rate with k(off) = 0.001 s-1 for sEGFR dimers as compared to k(off) = 0.06 s-1 for sEGFR monomers. These measurements indicate that dimerization of sEGFR increases its affinity for EGF by prolonging the amount of time that EGF remains bound to the receptor. This provides evidence that EGF binding stabilizes receptor dimerization and provides further support for the allosteric dimerization model as a mechanism for ligand induced receptor activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Macromolecular Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8193-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8347619-Animals,
pubmed-meshheading:8347619-Binding Sites,
pubmed-meshheading:8347619-CHO Cells,
pubmed-meshheading:8347619-Cricetinae,
pubmed-meshheading:8347619-Epidermal Growth Factor,
pubmed-meshheading:8347619-Humans,
pubmed-meshheading:8347619-Kinetics,
pubmed-meshheading:8347619-Macromolecular Substances,
pubmed-meshheading:8347619-Mice,
pubmed-meshheading:8347619-Receptor, Epidermal Growth Factor,
pubmed-meshheading:8347619-Recombinant Proteins,
pubmed-meshheading:8347619-Solubility,
pubmed-meshheading:8347619-Structure-Activity Relationship
|
pubmed:year |
1993
|
pubmed:articleTitle |
Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.
|
pubmed:affiliation |
Department of Pharmacology, New York University Medical Center, New York 10016.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|